These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36777097)

  • 21. Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma.
    Zhou C; Li C; Yan F; Zheng Y
    Cancer Cell Int; 2020 Nov; 20(1):541. PubMed ID: 33292199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of the ferroptosis-associated MGST1 gene in relation to poor outcome and maladjusted immune cell infiltration in uterine corpus endometrial carcinoma.
    Yan J; Ye G; Shao Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24317. PubMed ID: 35218676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma.
    Liu J; Chen T; Yang M; Zhong Z; Ni S; Yang S; Shao F; Cai L; Bai J; Yu H
    Front Cell Dev Biol; 2021; 9():753004. PubMed ID: 34901000
    [No Abstract]   [Full Text] [Related]  

  • 24. Positive Correlation Between LTA Expression and Overall Immune Activity Suggests an Increased Probability of Survival in Uterine Corpus Endometrial Carcinoma.
    Shi M; Luo F; Shao T; Zhang H; Yang T; Wei Y; Chen R; Guo R
    Front Cell Dev Biol; 2021; 9():793793. PubMed ID: 35155447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human
    Rathbun LA; Magliocco AM; Bamezai AK
    Oncotarget; 2023 May; 14():426-437. PubMed ID: 37141412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPP1R14B is a diagnostic prognostic marker in patients with uterine corpus endometrial carcinoma.
    He K; Wang T; Huang X; Yang Z; Wang Z; Zhang S; Sui X; Jiang J; Zhao L
    J Cell Mol Med; 2023 Mar; 27(6):846-863. PubMed ID: 36824011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis.
    Zhang Y; Wang J; Fan Y; Lang F; Fu F; Liu Q
    Clin Transl Oncol; 2024 Mar; 26(3):653-663. PubMed ID: 37523078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.
    Liu J; Ji C; Wang Y; Zhang C; Zhu H
    Cancer Cell Int; 2021 Jul; 21(1):365. PubMed ID: 34246261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods.
    Wu R; Wu C; Zhu B; Li J; Zhao W
    Front Mol Biosci; 2023; 10():1192313. PubMed ID: 37363398
    [No Abstract]   [Full Text] [Related]  

  • 30. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene
    Lin Y; Dong Y; Liu W; Fan X; Sun Y
    Int J Gen Med; 2022; 15():2501-2513. PubMed ID: 35282646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy.
    Zhu X; Yuan Z; Cheng S; Wang H; Liao Y; Zhou D; Wu Z
    World J Surg Oncol; 2022 Oct; 20(1):336. PubMed ID: 36207751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
    Lu X; Jing L; Liu S; Wang H; Chen B
    Int J Endocrinol; 2022; 2022():5006123. PubMed ID: 35719192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma.
    Zhang F; Wang Y; Li H; Li L; Yang X; You X; Tang L
    Front Oncol; 2023; 13():1118906. PubMed ID: 36925915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. m
    Fang F; Wang P; Huang H; Ye M; Liu X; Li Q
    BMC Cancer; 2022 Dec; 22(1):1364. PubMed ID: 36581816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.
    Shan L; Lu Y; Xiang CC; Zhu X; Zuo ED; Cheng X
    J Immunol Res; 2022; 2022():2547029. PubMed ID: 35571565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
    Zheng J; Zhang YW; Pan ZF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Expression of Pyroptosis-Related Gene May Influence the Occurrence, Development, and Prognosis of Uterine Corpus Endometrial Carcinoma.
    Huang X; Li Y; Li J; Yang X; Xiao J; Xu F
    Front Oncol; 2022; 12():885114. PubMed ID: 35574367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma.
    Wang F; Bi J; Yi C; Zhang Y; Zhang Y; Yue Q
    Contrast Media Mol Imaging; 2022; 2022():7376588. PubMed ID: 35655721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Infiltrates of m5C RNA Methylation-Related LncRNAs in Uterine Corpus Endometrial Carcinoma.
    Gu WX; Chen Y; Wang W
    J Oncol; 2022; 2022():1531474. PubMed ID: 35392434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.